Hints and tips:
Related Special Reports
...“This fund mostly sails the rough seas of early-stage firms,” Greengold wrote for Morningstar....
...The deal, which will mark a two-thirds expansion of Citadel’s London office space, comes after Griffin has expressed concern about how hybrid or working-from-home practices can hurt a company’s culture....
...Some have blamed this on Google’s fragmented structure, big-company bureaucracy and the lack of a coherent company-wide plan for rolling out generative AI across its range of products and services, the Financial...
...Lindsay Whitfield Professor of Business and Development Copenhagen Business SchoolFrederiksberg, Denmark...
...The talks with Apollo about a deal were at an early stage, said three of the people familiar with the matter....
...The progress made by Chinese companies and regulators in Beijing poses a new challenge to the west, which is already lagging behind China in the development of electric vehicles, according to analysts, and...
...French hotel group Accor is in talks with investment vehicle Dubai Holding to fund the roughly €800mn development of two upmarket cruise liners under the Orient Express brand, in the latest example of Middle...
...An attorney for Jane Street told Engelmayer that the firm had invested “tens of millions of dollars” into the development of the trading scheme....
...The Financial Times reported last month that the Canadian investment group was in late stage talks to acquire Castlelake, a specialist in originating highly rated debts backed by aircraft....
...After being approached by the Financial Times for comment, Amy Emerson, Lykos’ chief executive, said in a statement that the company “[looked] forward to the opportunity to discuss” its treatment application...
...Dean Meyer has joined venture capital firm Sequoia as a partner focused on early stage investments. He was previously an investor at Vine Ventures....
...Novavax will still be allowed to press ahead with the development of its combined Covid-flu shot, which is set to enter late-stage trials in the second half of this year....
...To some extent, this reflects special pleading by the tech companies....
...The company has a drug in mid-stage, phase 2 clinical trials that is a potential new treatment for advanced prostate cancer, the same treatment targeted by Pluvicto, a radioconjugate-based drug developed...
...Chief executive Lars Fruergaard Jørgensen told the Financial Times this month that it was assessing deals for biotech companies with mid-stage drugs....
...The discovery that a sufficient number of stem cells leak into the fluid for scientists to extract and grow into organoids will advance the development of prenatal treatments that ensure healthy births,...
...“It will encourage them to make sure the medicines are available here and it’s a route for people to get tested with the new medicines in development.”...
...It now has “several hundreds” of engineers dedicated to chip development, he added....
...Isomorphic Labs has partnerships with pharmaceutical companies Eli Lilly and Novartis....
...As the name suggests, this is a “business development company”, a weird but fascinating and uniquely American construct....
...Europe’s AI Act is an important development in balancing innovation and risk....
...AstraZeneca unveiled successes in the treatment of lung cancer on Monday, with its leading drug slowing progression of the disease at an early stage....
...According to health data company Airfinity, there are 232 anti-obesity medications at various stages of development, from pre-clinical studies on animals to late-stage, phase 3 trials....
...to raise $200mn to $300mn for its third fund — about twice as much as its last one — to invest in early stage private biotech companies, despite depressed share prices for listed biotechs....
...There have been a series of recent developments in the treatment of liver disease, which is the third-largest cause of early death in the UK and other high-income countries....
International Edition